Manufacturing day & Aspen Notre-Dame-De-Bondeville site visit – 29th November 2023

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively "Aspen" or "the Group")


MANUFACTURING DAY & ASPEN NOTRE-DAME-De-BONDEVILLE SITE VISIT – 29TH NOVEMBER 2023

Shareholders are advised that Aspen will be hosting a Manufacturing Day and site visit at its French facility
for shareholders, investor representatives and analysts on Wednesday, 29th November 2023 at 09h00 CAT
(GMT +2). Stakeholders interested in attending the site visit in-person are requested to contact Aspen
Investor Relations by emailing investorrelations@aspenpharma.com. Due to limited capacity on site, Aspen
reserves the right to manage the RSVP for in-person attendees.

Agenda:

08h00-08h30 Registration

09h00-10:30 Presentations (session 1)

10:30- 13:30 Site tour of the NDB facilities (session 2)

14:30-17:00 Presentations (session 3)

Sessions 1 and 3 will be available via webcast and can be accessed via the webcast link: https://edge.media-
server.com/mmc/p/s7m5v29z/.

A playback of the webcast will also be made available on Aspen's website, https://www.aspenpharma.com,
approximately 2 hours after the conclusion of the live presentation.

A copy of the presentation will be available on the Company's website, https://www.aspenpharma.com.

For any further details with regards to this, please contact Aspen Investor Relations by emailing
investorrelations@aspenpharma.com.

Durban
27 October 2023

Sponsor
Investec Bank Limited

Date: 27-10-2023 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.